A Hepatocellular Carcinoma Aggressiveness Index and Its Relationship to Liver Enzyme Levels

被引:32
作者
Carr, Brian I. [1 ]
Guerra, Vito [2 ]
机构
[1] Dokuz Eylul Univ, Izmir Biomed & Genome Ctr, TR-35340 Izmir, Turkey
[2] Natl Inst Digest Dis, IRCCS Bellis, Castellana Grotte, Italy
关键词
Liver function; Hepatocellular carcinoma; Aggressiveness; Index; PROGNOSIS; SURVIVAL; MICROENVIRONMENT;
D O I
10.1159/000444394
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Prognosis in hepatocellular carcinoma (HCC) is influenced by both liver and tumor factors, which have been considered independent influences. However, recent evidence has shown that the underlying liver also has prognostic information. Aims: To investigate possible relationships between liver function parameters and HCC aggressiveness indices. Methods: A large HCC patient database with baseline clinical information and survival data was retrospectively examined. Results: Data on 756 HCC patients with normal bilirubin were examined for a relationship between serum liver enzymes and 4 HCC aggressiveness indices of maximum tumor diameter, portal vein invasion, tumor multifocality or serum alpha-fetoprotein levels. An association was found between elevated enzyme levels and increased HCC aggressiveness. An aggressiveness index was constructed from the 4 indices and expressed as a sum of their scores, which in turn reflected 3 survival groups. In a Cox model, the hazard ratios for each of the groups were significantly different. Conclusions: Statistically significant correlations were found between standard liver function parameters and HCC aggressiveness. A composite aggressiveness index was constructed, yielding 3 groups with different survival probabilities. These findings support the concept of the importance of the underlying liver in relation to HCC biology. (C) 2016 S. Karger AG, Basel
引用
收藏
页码:215 / 220
页数:6
相关论文
共 17 条
[1]   Tumor and liver determinants of prognosis in unresectable hepatocellular carcinoma: A case cohort study [J].
Carr, Brian I. ;
Buch, Shama C. ;
Kondragunta, Venkateswarlu ;
Pancoska, Petr ;
Branch, Robert A. .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 (08) :1259-1266
[2]   Association of Abnormal Plasma Bilirubin With Aggressive Hepatocellular Carcinoma Phenotype [J].
Carr, Brian I. ;
Guerra, Vito ;
Giannini, Edoardo G. ;
Farinati, Fabio ;
Ciccarese, Francesca ;
Rapaccini, Gian Ludovico ;
Di Marco, Maria ;
Benvegniu, Luisa ;
Zoli, Marco ;
Borzio, Franco ;
Caturelli, Eugenio ;
Chiaramonte, Maria ;
Trevisani, Franco .
SEMINARS IN ONCOLOGY, 2014, 41 (02) :252-258
[3]   Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing nonsurgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre [J].
Grieco, A ;
Pompili, M ;
Caminiti, G ;
Miele, L ;
Covino, M ;
Alfei, B ;
Rapaccini, GL ;
Gasbarrini, G .
GUT, 2005, 54 (03) :411-418
[4]   Role of the Microenvironment in the Pathogenesis and Treatment of Hepatocellular Carcinoma [J].
Hernandez-Gea, Virginia ;
Toffanin, Sara ;
Friedman, Scott L. ;
Llovet, Josep M. .
GASTROENTEROLOGY, 2013, 144 (03) :512-527
[5]   Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma [J].
Hoshida, Yujin ;
Villanueva, Augusto ;
Kobayashi, Masahiro ;
Peix, Judit ;
Chiang, Derek Y. ;
Camargo, Amy ;
Gupta, Supriya ;
Moore, Jamie ;
Wrobel, Matthew J. ;
Lerner, Jim ;
Reich, Michael ;
Chan, Jennifer A. ;
Glickman, Jonathan N. ;
Ikeda, Kenji ;
Hashimoto, Masaji ;
Watanabe, Goro ;
Daidone, Maria G. ;
Roayaie, Sasan ;
Schwartz, Myron ;
Thung, Swan ;
Salvesen, Helga B. ;
Gabriel, Stacey ;
Mazzaferro, Vincenzo ;
Bruix, Jordi ;
Friedman, Scott L. ;
Kumada, Hiromitsu ;
Llovet, Josep M. ;
Golub, Todd R. .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (19) :1995-2004
[6]   Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach-The ALBI Grade [J].
Johnson, Philip J. ;
Berhane, Sarah ;
Kagebayashi, Chiaki ;
Satomura, Shinji ;
Teng, Mabel ;
Reeves, Helen L. ;
O'Beirne, James ;
Fox, Richard ;
Skowronska, Anna ;
Palmer, Daniel ;
Yeo, Winnie ;
Mo, Frankie ;
Lai, Paul ;
Inarrairaegui, Mercedes ;
Chan, Stephen L. ;
Sangro, Bruno ;
Miksad, Rebecca ;
Tada, Toshifumi ;
Kumada, Takashi ;
Toyoda, Hidenori .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (06) :550-U45
[7]   The Glasgow Prognostic Score, an inflammation based prognostic score, predicts survival in patients with hepatocellular carcinoma [J].
Kinoshita, Akiyoshi ;
Onoda, Hiroshi ;
Imai, Nami ;
Iwaku, Akira ;
Oishi, Mutumi ;
Tanaka, Ken ;
Fushiya, Nao ;
Koike, Kazuhiko ;
Nishino, Hirokazu ;
Matsushima, Masato ;
Saeki, Chisato ;
Tajiri, Hisao .
BMC CANCER, 2013, 13
[8]   Prognosis of hepatocellular carcinoma:: The BCLC staging classification [J].
Llovet, JM ;
Brú, C ;
Bruix, J .
SEMINARS IN LIVER DISEASE, 1999, 19 (03) :329-338
[9]  
Manghisi G, 1998, HEPATOLOGY, V28, P751
[10]  
OKUDA K, 1985, CANCER-AM CANCER SOC, V56, P918, DOI 10.1002/1097-0142(19850815)56:4<918::AID-CNCR2820560437>3.0.CO